Xenon Pharmaceuticals stock launched Monday, hitting a record high, on "unprecedented" results for its seizure drug.

Hope for Alzheimer's prevention emerges as scientists find existing seizure drug may stop disease progression if taken ...

Research Triangle Park, NC (January 20, 2002) – GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) granted marketing clearance for Lamictal® (lamotrigine) Tablets as ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The FDA has granted approval to Azurity Pharmaceuticals ...

Dravet syndrome affects about 1 in 17,500 children. Having two daughters with the condition is “extraordinarily uncommon.” ...

The Food and Drug Administration on Wednesday approved Eisai’s epilepsy drug Fyompa as a primary treatment for partial-onset seizures in epileptic patients 12 years or older. Here are three things to ...

Vomiting 2.5 5.9 8.5 Vision blurred 2.5 2.2 8.5 Somnolence 4.7 5.2 8.1 Nasopharyngitis 5.8 6.3 7.6 Fatigue 5.8 7.0 7.2 Coordination abnormal 1.6 4.1 7.2 Tremor 4.1 3.7 6.2 Balance disorder 0.0 1.1 5.1 ...

Planning ahead for his next seizure was Brian George's daily schedule − even at work − for more than 20 years. "You adapt," he said. "You're always thinking, 'What if I have one?' You’re in a new ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved an expanded indication for Briviact CV tablets, oral solution and injection, for treating ...